A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/72 (2006.01) A61K 9/12 (2006.01) A61K 31/00 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2122719
2122719 9309764 PCTABS00022 The common cold and related disorders such as influenza, acute sinusitis, acute otitis, and infectious exacerbations of obstructive pulmonary disease, are best treated by providing a combination of antiviral agents and antiinflammatory compounds to a patient infected with a cold or influenza virus. An antiviral agent and two antiinflammatory compounds given to a person infected with a cold virus simultaneously reduces the likelihood of a cold developing and the amount and duration of viral shedding, as well as substantially reduces the severity of individual cold symptoms and the overall number and severity of cold symptoms. Supplementing the activity of the combined antiviral and antiinflammatory agents with such compounds as antihistamines and alpha agonists results in suprisingly good nasal benefits. The combination therapy, termed COVAM therapy, is well tolerated and has no evidence of short-term toxicity.
Macrae & Co.
University Of Virginia Patent Foundation
LandOfFree
Combined virustatic antimediator (covam) treatment of common... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined virustatic antimediator (covam) treatment of common..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined virustatic antimediator (covam) treatment of common... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1871672